Skip to content

Continuous Erector Spinal Plane Block versus Intercostal Nerve Block Combined with Patient-Controlled Intravenous Analgesia in Postoperative Pain Management of Radical Lung Cancer Surgery: A Randomized Controlled Trial

Continuous Erector Spinal Plane Block versus Intercostal Nerve Block Combined with Patient-Controlled Intravenous Analgesia in Postoperative Pain Management of Radical Lung Cancer Surgery: A Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400089595
Enrollment
Unknown
Registered
2024-09-11
Start date
2023-04-01
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative analgesia for radical resection of pulmonary carcinoma

Interventions

Group E, the continuous erector spinae plane block analgesia group:Before surgery, puncture and catheterization were performed on the plane of the erector spinae muscle, and a loading dose was admini
Group C, control group: single intercostal nerve block combined with PCIA analgesia group:Intercostal nerve block combined with PCIA

Sponsors

The First Affiliated Hospital of Guangzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 42 patients underwent elective thoracoscopic surgery and right upper lobectomy, aged 18-65 years, with a BMI of 18.5-24.0kg/m2, ASA grade I-II, regardless of gender. No history of local anesthesia allergy, no history of mental illness, no infection at the puncture site, no difficult airway or other related pulmonary complications; No abnormalities were found in liver, kidney, and coagulation functions. Routine fasting and no preoperative medication were used.

Exclusion criteria

Exclusion criteria: 1) Patients and their families refused to participate in this study; (2) Patients and their families refuse to sign relevant informed consent forms; (3) Patients with central or (and) peripheral nervous system disorders; (4) Patients with mental illness who are unable to cooperate and communicate; (5) Patients with coagulation dysfunction; (6) Patients with skin damage around puncture; (7) Patients who are allergic to local anesthetics; (8) Patients who have recently taken non steroidal drugs; (9) Patients with a history of drug abuse; (10) Patients with abnormal liver and kidney function.

Design outcomes

Primary

MeasureTime frame
Postoperative NRS score;

Secondary

MeasureTime frame
Patient's fatigue condition one week after surgery;Changes in patient lung function before and after surgery;Postoperative adverse reactions;

Countries

China

Contacts

Public ContactWenBo Diao

Shenzhen People’s Hospital

2586810091@qq.com+86 137 9858 5134

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026